ArticleMicroorganisms2026
From Trends to Insights: Management of Periprosthetic Joint Infections in the Past Decade in The Netherlands.
Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevention and optimal treatment of periprosthetic joint infections (PJI), including antibiotic prophylaxis and DAIR (debridement, antibiotics, and implant retention), is a controversial topic. This study evaluated treatment trends over the past 10 years in the Netherlands. In November 2024, all Dutch institutions performing total hip or knee arthroplasties were contacted to complete a 21-question survey on the availability of a protocol, antibiotic prophylaxis, and treatment of PJIs. Results were compared with previously performed surveys (2013, 2016 and 2019) to describe trends in the past decade of PJI prevention and treatment. The survey response rate was 100%. The use of single-dose antibiotic prophylaxis increased from 10% in 2016 to 49% in 2024. An acute PJI protocol was present in 72% of the institutions in 2016 and 95% in 2024. During DAIR procedures, mobile components were exchanged in 94% of the institutions, whereas in 2013 this reportedly happened in only 41%. In 77% of the institutions, a periodic multidisciplinary infection meeting is implemented, representing a 22% increase since 2013. These findings demonstrate a clear tendency towards standardization and optimization of the treatment of periprosthetic infections in the Netherlands over the past decade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.